Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 43,146 | 1,521 | 1,964 | 2,479 | 5,915 |
| Cost of Goods | 754 | N/A | N/A | N/A | 78 |
| Gross Profit | 42,392 | 1,521 | 1,964 | 3,331 | 5,836 |
| Operating Expenses | 36,535 | 30,063 | 26,270 | 19,630 | 27,843 |
| Operating Income | 6,611 | -28,543 | -24,306 | -17,151 | -21,929 |
| Interest Expense | 862 | 20,081 | 4,912 | 11,552 | 1,416 |
| Other Income | 4,884 | 1,718 | 1,072 | -882 | 2,555 |
| Pre-tax Income | 10,633 | -46,905 | -28,146 | -29,585 | -20,790 |
| Income Tax | -192 | -226 | -244 | -2,543 | -240 |
| Net Income Continuous | 10,825 | -46,679 | -27,902 | -27,042 | -20,550 |
| Net Income Discontinuous | N/A | N/A | N/A | -19,649 | 479 |
| Net Income | $10,825 | $-46,679 | $-27,902 | $-46,691 | $-20,071 |
| EPS Basic Total Ops | 0.19 | -0.80 | -0.54 | -0.89 | -0.43 |
| EPS Basic Continuous Ops | 0.19 | -0.80 | -0.54 | -0.49 | -0.44 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.41 | 0.01 |
| EPS Diluted Total Ops | 0.18 | -0.80 | -0.54 | -0.89 | -0.43 |
| EPS Diluted Continuous Ops | 0.18 | -0.80 | -0.54 | -0.49 | -0.44 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.41 | 0.01 |
| EBITDA(a) | $6,611 | $-28,543 | $-24,306 | $-17,151 | $-21,929 |